Recursion pharmaceuticals stock

Top Analyst Stocks Popular. Bitcoin Popular.

Add to a list Add to a list. To use this feature you must be a member. Recursion Pharmaceuticals, Inc. Funds and ETFs. Exceptional extension!

Recursion pharmaceuticals stock

Yesterday, the company made a big announcement at the J. Morgan Healthcare Conference. Additionally, growth investor Cathie Wood continues to load up on shares of RXRX stock, leading to what appears to be some coattail-riding from momentum investors. Indeed, this is one application of large language models that investors have been waiting for. In the biotech world, being able to develop drugs in a more inexpensive and expedited fashion could lead to massive productivity and margin gains for companies using the tool. How the spoils will be split up is another question — and one with which the market will need to grapple. For now, though, the move has obviously been up and to the right for RXRX stock, for good reason. Notably, the combination of biotech and AI exposure that Recursion provides is also going to drive more interest in the stock from the likes of Cathie Wood and similar-minded growth investors. If this technology pans out the way that many expect, there could be some massive upside ahead. On the date of publication, Chris MacDonald did not hold either directly or indirectly any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.

Find out before anyone else which stock is going to shoot up. The company was founded by Blake Borgeson, Christopher C.

Top Analyst Stocks Popular. Bitcoin Popular. Gold New. Unusual Options Activity Popular. Research Tools.

Key events shows relevant news articles on days with large price movements. Crispr Therapeutics AG. CRSP 0. Absci Corp. ABSI 3. Tilray Brands Inc. TLRY 0.

Recursion pharmaceuticals stock

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Morningstar brands and products. Investing Ideas. Unlock our analysis with Morningstar Investor. Start Free Trial.

Oem tools

This Week 7 articles. Today 1. Morgan Healthcare Conference. Dividend Yield Calculator. Dean Li td:not. Know what industry insiders are buying. What are Recursion Pharmaceuticals, Inc. RXRX chart. Lots of recent block buys and kind of a middle high short float. Unusual Options Activity Popular. TipRanks Labs. Student Loan Calculator. Chart Recursion Pharmaceuticals, Inc.

.

REC is developed for the treatment of neurofibromatosis type 2. Managers and Directors - Recursion Pharmaceuticals, Inc. ETF Center. The opinions expressed in this article are those of the writer, subject to the InvestorPlace. Morgan Stanley. Average Return. Dividends Dividend Center. Price to earnings Ratio TTM. Top Stocks. Highs and lows.